[email protected]

01252 375362

[email protected]    /    01252 375362

FDA crackdown on illegal meds

by | Jul 19, 2015 | Analyisis, Behind the scenes, Blog, Falsified Medicines, Good Distribution Practice - GDP, MHRA, Pharmacy Suppliers, Regulation, RP, WDA(H), WDA(H)

In May, the FDA in conjunction with international law enforcements agencies enforced a major crackdown on illegal and crackdown medications with action taken against 1,050 websites.

Seized products were found to have originated in India, China, Hong Kong and Singapore.  Medicines seized included antidepressants, hormone replacement therapies, sleep aids, erectile dysfunction medications and anti-cholesterol medications.  Devices included colon-care products and dermal filers.

Coming from this, the FDA is also providing information on how to identify illegal medication and pharmacy websites via an initiative entitled “BeSafeRx: Know Your Online Pharmacy.”

On the back of this investigation, the MHRA inspected more than 150,000 packages and announced a haul of 15.8 million pounds worth of illegal medications and devices.

Would your pharmacy and/or wholesale staff know how to identify counterfeit/illegal medications?

Are you at ris? And how can you mitigate?

Testimonials

Having just completed the very informative API and Clinical Trail course (thank you Shankar) I was reminded of the traps we can fall into whereby we try to keep ourselves in our little boxes. At the MHRA symposium, I have heard several times comments such as:- “no, I’m not doing the GMP day as it’s not relevant to me” or “GDP? Oh, that doesn’t apply to us as we are manufacturers”. I am sure these comments were made well out of the earshot of MHRA personnel and on the face of it see… Read more
API and Clinical Trails Training